An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2009.02775.x/fullpdf
Reference89 articles.
1. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group;Vignati;Clin Ther,1997
2. Insulin strategies for primary care providers;Herbst;Clinical Diabetes,2002
3. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analogue lispro in variable combination with NPH insulin at mealtime;Lalli;Diabetes Care,1999
4. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analogue treatment. Multicenter Insulin Lispro Study Group;Anderson;Diabetes,1997
5. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes;Pfutzner;Exp Clin Endocrinol Diabetes,1996
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating the Impact of Intensifying Treatment from Human to Analogue Insulin on Glycaemic Control and Insulin Expenditure in Patients with Type 2 Diabetes: A Retrospective Cohort Study;Malaysian Journal of Medical Sciences;2024-04-23
2. Prandial Insulins: A Person-Centered Choice;Current Diabetes Reports;2024-04-03
3. A cost of illness study evaluating the burden of Wolfram syndrome in the United Kingdom;Orphanet Journal of Rare Diseases;2019-07-31
4. Facilitating the transition of young people with long-term conditions through health services from childhood to adulthood: the Transition research programme;Programme Grants for Applied Research;2019-05
5. Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting;Diabetes, Obesity and Metabolism;2017-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3